<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The diagnosis of <z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome (AS)</z:e> is based on the clinical features, behavior, EEG findings, and genetic abnormalities </plain></SENT>
<SENT sid="1" pm="."><plain>The physical, clinical and behavioral aspects appear to attributable to localized central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) dysfunction of the ubiquitin ligase gene, UBE3A, located at 15q11.2 </plain></SENT>
<SENT sid="2" pm="."><plain>The features of AS frequently become apparent at 1-4 years of age, and the average age at diagnosis is 6 years </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> was considered in the differential diagnosis of 30 patients who were referred to the Medical Genetics Department of Istanbul Medical Faculty between 1995 and 2005 </plain></SENT>
<SENT sid="4" pm="."><plain>The diagnosis was confirmed in 14 patients (8 female, 6 male) by detecting the presence of deletion through the use of fluorescence in situ hybridization (FISH) technique in <z:hpo ids='HP_0000001'>all</z:hpo>, while high-resolution banding technique (HRBT) detected only seven of the deletions </plain></SENT>
<SENT sid="5" pm="."><plain>The patients' ages at the time of diagnosis ranged from 2 to 12 (mean 4.10+/-2.59) years </plain></SENT>
<SENT sid="6" pm="."><plain>We report here on 14 patients with definite diagnosis of AS who displayed the characteristic clinical features of the syndrome and additional findings not previously reported, along with the follow-up data concerning neuromotor development and <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
</text></document>